Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-057067

Director sold 33,750 shares at an average $136.68 ($4,612,976)

  • Director acquired 33,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hindson Benjamin J. · Director

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Exercise or conversion : show line 1 in the form +21,062 $0.88 $18,535 88,562 D
2020-11-02 Sale : show line 2 in the form −3,328 $135.36 $450,467 85,234 D
2020-11-02 Sale : show line 3 in the form −13,242 $136.11 $1,802,377 71,992 D
2020-11-02 Sale : show line 4 in the form −1,940 $136.98 $265,739 70,052 D
2020-11-02 Sale : show line 5 in the form −1,146 $138.06 $158,212 68,906 D
2020-11-02 Sale : show line 6 in the form −1,406 $139.13 $195,622 67,500 D
2020-11-03 Exercise or conversion : show line 7 in the form +12,688 $0.88 $11,165 80,188 D
2020-11-03 Sale : show line 8 in the form −398 $135.52 $53,936 79,790 D
Open-market sales · 33,750 sh · avg $136.68 · $4,612,976

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-11-02 Exercise or conversion : show line 12 in the form Stock Option (right to buy) −21,062 $0.88 2025-10-27 21,062 91,438 D
2020-11-03 Exercise or conversion : show line 13 in the form Stock Option (right to buy) −12,688 $0.88 2025-10-27 12,688 78,750 D
Loading xslF345X03/doc4.xml…